BAK · NYSE · CIK 0001071438

BRASKEM SA

BRASKEM SA’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 26, 2026. In fiscal 2024 (year ended Dec 31, 2024) it reported revenue of BRL 77.4B and net income of -BRL 12.1B, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2024
BRL 77.4B
Net income, FY2024
-BRL 12.1B
Form 4 filings on record, past 12 months
0

Company overview

Legal name (as filed)
BRASKEM SA
Ticker
BAK
SEC Central Index Key (CIK)
0001071438
Industry (SIC)
Industrial Organic Chemicals (code 2860)
Business address
CAMACARI BAHIA BRAZI
State or country of incorporation
—
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2741 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from BRASKEM SA’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in BRL; the fiscal year is named for the calendar year in which it ends.

Revenue
BRL 58.5BFY2020BRL 105.6BFY2021BRL 96.5BFY2022BRL 70.6BFY2023BRL 77.4BFY2024
Net income
-BRL 7.0BFY2020BRL 14.0BFY2021-BRL 821.0MFY2022-BRL 4.9BFY2023-BRL 12.1BFY2024
BAK annual results
ItemFY2020
ended Dec 31, 2020		FY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024
RevenueBRL 58.5BBRL 105.6BBRL 96.5BBRL 70.6BBRL 77.4B
Net income-BRL 7.0BBRL 14.0B-BRL 821.0M-BRL 4.9B-BRL 12.1B
Diluted EPS-BRL 8.41BRL 17.57———
Total assetsBRL 86.1BBRL 92.6BBRL 88.0BBRL 91.7BBRL 101.6B
Cash and equivalentsBRL 13.9BBRL 8.7BBRL 12.5BBRL 14.2BBRL 15.0B

XBRL tags used: revenue = Revenue; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

BAK latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Apr 20, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 26, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about BRASKEM SA, by form type:

6-K ×376-K/A ×23 ×1
BAK recent filings
FiledFormWhat it isOriginal
Oct 26, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Oct 22, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Oct 22, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Oct 22, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Oct 13, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Oct 13, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Sep 28, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Sep 25, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Sep 11, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Sep 11, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Sep 10, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 28, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 27, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 26, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 25, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 25, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 25, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 24, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 24, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 24, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 21, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 19, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 18, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 18, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 14, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Aug 14, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Aug 14, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Aug 11, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 11, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Aug 11, 20266-K/A6-K/A· period Jun 30, 2026Document · Index
Aug 3, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Jul 31, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Jul 29, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Jul 22, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Jul 21, 20266-K/A6-K/A· period Sep 30, 2026Document · Index
Jul 16, 20263Initial statement of beneficial ownership· period Jul 10, 2026Document · Index
Jul 13, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Jul 13, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Jul 13, 20266-KReport of a foreign private issuer· period Sep 30, 2026Document · Index
Jun 30, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index

Insider filing activity

0 Form 4 filings appear in BRASKEM SA’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Industrial Organic Chemicals

All 10 companies in Industrial Organic Chemicals

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001071438 and XBRL company facts. BRASKEM SA on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.